Clinicians recognize that warm autoimmune haemolytic anaemia disproportionately affects older demographics and female patients. However, the precise immunological cascades that trigger loss of self-tolerance to red blood cell antigens have remained elusive. Recent groundbreaking research illustrates that ageing and sex fundamentally reshape adaptive immune compartments over time. Consequently, peripheral CD4 T-cell regulatory barriers steadily deteriorate, permitting autoreactive clones to escape suppression and generate pathogenic anti-erythrocyte autoantibodies.

Pathophysiology of Warm Autoimmune Haemolytic Anaemia Across Age and Sex

Warm autoimmune haemolytic anaemia represents a challenging hematologic disorder characterized by the premature destruction of erythrocytes by immunoglobulin G autoantibodies. Preclinical models confirm that tolerance against red blood cell antigens relies heavily on robust peripheral CD4 T-cell checkpoints. In young and healthy physiology, peripheral regulatory mechanisms suppress autoreactive T-cell populations that escape negative thymic selection. Consequently, autoreactive helper cells remain quiescent, preventing any downstream activation of pathogenic B-cell clones.

However, chronological ageing introduces pervasive shifts across the immune landscape. Researchers observe that senescence alters lymphoid architecture and skews immune lineage differentiation. Simultaneously, biological sex modulates these dynamics through distinct hormonal and genetic influences. For instance, estrogen receptor signalling and X-chromosome dosage significantly alter lymphocyte activation thresholds. When ageing converges with female biological sex, the physiological resilience of regulatory checkpoints declines noticeably. Therefore, this intersection fosters a permissive microenvironment where erythrocyte-specific autoantigens gradually trigger pathological immune responses.

Remodelling of B-Cell Subsets and Age-Associated B Cells

Recent mechanistic investigations reveal substantial remodelling within humoral immune compartments during healthy ageing. Specifically, investigators identified an expansion of innate-like B1 cells alongside a prominent accumulation of CD11c-positive, T-bet-expressing age-associated B cells. These specialized age-associated B cells, frequently termed ABCs, display unique functional traits that distinguish them from conventional follicular B lymphocytes. Furthermore, ABCs demonstrate heightened responsiveness to innate pattern-recognition signals, such as Toll-like receptors, and resist typical apoptotic signals.

Importantly, this atypical B-cell population exhibits robust antigen-presenting capabilities. As ABCs expand within lymphoid tissues, they interact continuously with self-reactive CD4 T cells. Moreover, these cells secrete elevated baseline quantities of pro-inflammatory cytokines, which destabilize peripheral immune stasis. Because females accumulate age-associated B cells more rapidly than males, humoral tolerance experiences greater structural stress in older female subjects. Thus, the expansion of ABCs acts as an essential immunological bridge, directly linking chronological ageing to the emergence of erythrocyte-specific autoantibodies.

Pro-Inflammatory CD4 T-Cell Shifts and Effector Polarization

Parallel to B-cell alterations, the helper T-cell compartment undergoes marked phenotypic rewiring. In senescent hosts, naive CD4 T cells steadily decline while antigen-experienced memory cells expand. Crucially, researchers identified a pronounced phenotypic bias toward pro-inflammatory T helper-1 phenotypes that produce significant amounts of interferon-gamma. Additionally, older immune profiles exhibit an increase in CD39-expressing CD4 T cells, reflecting chronic activation and persistent immune stimulation.

This shift toward an interferon-gamma-dominated milieu significantly amplifies tissue inflammation. Furthermore, elevated interferon-gamma promotes the upregulation of major histocompatibility complex class II molecules on professional and non-professional antigen-presenting cells. As a result, cryptic red blood cell epitopes gain greater exposure within the splenic microenvironment. Autoreactive effector CD4 T cells subsequently provide critical cognate help to autoantibody-producing B cells. Therefore, this cytokine polarization systematically undermines peripheral tolerance, actively sustaining autoimmune hemolysis over time.

Decay of Regulatory T-Cell Suppression in Adult Females

Peripheral immune tolerance relies fundamentally on CD4-positive regulatory T cells to restrain autoantigen-primed effector cells. Experimental findings reveal that young hosts preserve functional regulatory pathways that successfully neutralize autoreactive T-cell clones. Unfortunately, total regulatory T-cell frequencies decline significantly as organisms advance in age. More critically, the intrinsic suppressive competence of regulatory T cells deteriorates markedly in adult female hosts.

Functional suppression assays demonstrate that regulatory T cells from adult female subjects lose their ability to suppress autoreactive helper T-cell proliferation. Notably, this functional breakdown coincides precisely with the temporal window wherein pathogenic autoantibodies first manifest in circulation. Although male subjects experience some degree of senescent remodelling, female regulatory T cells exhibit far greater functional degradation. Consequently, this sex-biased regulatory impairment creates an open immunologic window, directly facilitating the survival and propagation of pathogenic erythrocyte-targeted clones.

Translational and Clinical Implications for Hematologists

These preclinical insights provide valuable implications for clinical hematologists managing refractory autoimmune cytopenias. First, understanding that age and sex dismantle regulatory barriers helps clinicians contextualize why elderly female patients frequently experience more aggressive or relapsing clinical courses. Furthermore, recognizing that age-associated B cells and interferon-gamma-producing helper T cells drive disease pathogenesis opens new therapeutic avenues beyond general corticosteroids.

Modern hematology relies increasingly on targeted immunotherapies rather than broad immunosuppression. Because conventional therapies like systemic steroids carry severe metabolic and infectious toxicities in older adults, targeted interventions offer appealing advantages. Therapeutic strategies that neutralize B-cell survival factors, inhibit T-bet-driven ABC differentiation, or restore regulatory T-cell suppressive capacity could transform disease management. Ultimately, delineating these precise cellular vulnerabilities empowers physicians to tailor individualized treatment regimens, improving long-term outcomes for patients with warm autoimmune haemolytic anaemia.

Frequently Asked Questions

How do age-associated B cells contribute to autoimmune haemolytic anaemia?

Age-associated B cells accumulate progressively with chronological age, particularly in female individuals. These cells express CD11c and the transcription factor T-bet, conferring enhanced antigen-presenting capabilities. Furthermore, age-associated B cells resist standard apoptotic clearance mechanisms and release pro-inflammatory cytokines. Consequently, they effectively present red blood cell autoantigens to autoreactive helper T cells, driving the persistent generation of pathogenic autoantibodies.

Why does female sex increase susceptibility to peripheral tolerance failure?

Female biology involves specific hormonal dynamics and genetic factors, including incomplete X-chromosome inactivation, which elevate immune responsiveness. Research indicates that regulatory T cells in adult females experience an accelerated loss of suppressive potency during middle age. As a result, regulatory networks fail to adequately suppress self-reactive effector T cells, creating a permissive environment for autoimmune hemolytic disease.

What are the practical clinical implications for managing elderly patients?

Elderly patients with autoimmune hemolytic anemia often present with higher relapse rates and severe treatment-related side effects from prolonged steroid regimens. Understanding that progressive B- and T-cell remodeling underpins the disease emphasizes the need for steroid-sparing approaches. Hematologists should consider early targeted B-cell depletion, rigorous infection surveillance, and potential immunomodulatory therapies designed to restore peripheral T-cell tolerance safely.

Disclaimer: This content is for informational and educational purposes only. It is not intended to substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

Dei Zotti F et al. Ageing and female sex progressively remodel B- and T-cell compartments to strain peripheral T-cell tolerance to red blood cell autoantigens. Br J Haematol. 2026 Oct 30. doi: 10.1111/bjh.70912. PMID: 42963193.

Berentsen S, Barcellini W. Autoimmune Hemolytic Anemias. N Engl J Med. 2021;385(15):1407-1419.

Brodsky RA. Warm Autoimmune Hemolytic Anemia. Blood. 2019;133(17):1821-1830.